# Gate Status — Benchmark Mode

## Gate — Iteration 1 (Milestone B1: Repository Inventory, Evidence Ledger & Prior-Art Audit)
| Agent | Role | Verdict | Source |
|-------|------|---------|--------|
| explorer_b1_1 | teamwork_preview_explorer | DONE (ledger & inventory) | handoff.md |
| explorer_b1_2 | teamwork_preview_spec_miner | DONE (prior-art & novelty) | handoff.md |
| worker_b1 | teamwork_preview_worker | DONE (build passed) | handoff.md |
| reviewer_b1_1 | teamwork_preview_reviewer | APPROVE (changes verified) | handoff.md |
| reviewer_b1_2 | teamwork_preview_reviewer | APPROVE | handoff.md |
| challenger_b1_1 | teamwork_preview_challenger | APPROVE | handoff.md |
| challenger_b1_2 | teamwork_preview_challenger | APPROVE | handoff.md |
| auditor_b1 | teamwork_preview_auditor | CLEAN | handoff.md |

Gate Result: **PASS**

---

## Gate — Iteration 2 (Milestone B2: Falsifiable Hypotheses & Independent Recalculation)
| Agent | Role | Verdict | Source |
|-------|------|---------|--------|
| explorer_b2_hypotheses | teamwork_preview_explorer | DONE (hypotheses H1-H3) | handoff.md |
| explorer_b2_recalc | teamwork_preview_explorer | DONE (recalc architecture) | handoff.md |
| explorer_b2_sensitivity | teamwork_preview_explorer | DONE (sensitivity design) | handoff.md |
| worker_b2 | teamwork_preview_worker | DONE (build passed) | handoff.md |
| reviewer_b2_1 | teamwork_preview_reviewer | APPROVE | handoff.md |
| reviewer_b2_2 | teamwork_preview_reviewer | APPROVE | handoff.md |
| challenger_b2_1 | teamwork_preview_challenger | APPROVE | handoff.md |
| challenger_b2_2 | teamwork_preview_challenger | APPROVE | handoff.md |
| auditor_b2 | teamwork_preview_auditor | CLEAN | handoff.md |

Gate Result: **PASS**
All acceptance criteria for Milestone B2 (Requirements R3 & R4) have been verified:
1. `results/research/question_and_hypotheses.md`: Competing hypotheses H1, H2, H3 with non-circular, quantitative support and falsification thresholds.
2. `src/telotrade/independent/recalculate.py`: 100% isolated independent recalculation engine using Bio.SVDSuperimposer, Gemmi superpose_positions, SciPy cKDTree, and FreeSASA/Biopython ShrakeRupley.
3. `results/validation/independent_metrics.csv`: 26 independently recalculated metrics with delta and percent difference matching PROJECT.md.
4. `results/interface/sensitivity_analysis.csv`: 32 residue pairs partitioned into Core Persistent (5), Intermediate Boundary (16), and Peripheral / Sensitive (11) across 3.5, 4.0, 4.5 Å cutoffs.
5. Test suite: 319 passed, 0 failed.
6. Forensic Audit: CLEAN.

---

## Gate — Iteration 3 (Milestone B3: Mechanistic DE-Loop, Allostery & TELIN-1 Ligand Audit)
| Agent | Role | Verdict | Source |
|-------|------|---------|--------|
| explorer_b3_deloop | teamwork_preview_explorer | DONE (DE-loop report) | handoff.md |
| explorer_b3_allostery | teamwork_preview_explorer | DONE (allostery assessment) | handoff.md |
| explorer_b3_telin1 | teamwork_preview_explorer | DONE (TELIN-1 audit) | handoff.md |
| reviewer_b3_1 | teamwork_preview_reviewer | APPROVE (DE-loop & allostery) | handoff.md |
| reviewer_b3_2 | teamwork_preview_reviewer | APPROVE (TELIN-1 quarantined) | handoff.md |
| challenger_b3_1 | teamwork_preview_challenger | APPROVE (stress-tests passed) | handoff.md |
| challenger_b3_2 | teamwork_preview_challenger | APPROVE (chemical audit confirmed) | handoff.md |
| auditor_b3 | teamwork_preview_auditor | CLEAN (binary veto cleared) | handoff.md |

Gate Result: **PASS**
All acceptance criteria for Milestone B3 (Requirements R5 & R6) have been verified:
1. `results/mechanism/de_loop_mechanism_report.md`: Refutes CLM-021; establishes state-dependent order-disorder loop transition without unproven temporal sequence.
2. `results/mechanism/allostery_evidence_assessment.md`: Refutes CLM-022; details why 0.338 Å RMSD falls within experimental noise and cannot rule out dynamic/entropic allostery.
3. `results/ligand/TELIN1_evidence_audit.md`: Audits putative inhibitor TELIN-1; proves chemical fragmentation and 160 severe clashes, placing it under quarantine.

---

## Gate — Iteration 4 (Milestone B4: Translation, Predictions & Adversarial Review)
| Agent | Role | Verdict | Source |
|-------|------|---------|--------|
| translator_b4 | teamwork_preview_worker | DONE (matrix & window reports) | results/translation |
| validator_b4 | teamwork_preview_worker | DONE (wet-lab protocols) | results/validation_experiments |
| redteam_b4 | teamwork_preview_challenger | APPROVE (adversarial audit) | results/final_adversarial_review.md |
| auditor_b4 | teamwork_preview_auditor | CLEAN | results/final_adversarial_review.md |

Gate Result: **PASS**
All acceptance criteria for Milestone B4 (Requirement R7 part 1) have been verified:
1. `results/translation/cancer_aging_evidence_matrix.csv`: 6-column matrix mapping cancer vs stem-cell dependencies, Hoyeraal-Hreidarsson syndrome, Dyskeratosis Congenita, and ALT pathway.
2. `results/translation/therapeutic_window_limits.md`: In-depth analysis of the kinetic lag paradox and why total interface shutdown causes lethal bone marrow failure.
3. `results/validation_experiments/falsifiable_predictions.md`: Concrete wet-lab protocols for stopped-flow kinetics, HDX-MS, smFRET, and mutational RAP assays with non-circular falsification criteria.
4. `results/final_adversarial_review.md`: Exhaustive multi-perspective red-team audit deconstructing all claims and certifying scientific integrity.

---

## Gate — Iteration 5 (Milestone B5: 13-Section Report Rewrite & Final Forensic Verification)
| Agent | Role | Verdict | Source |
|-------|------|---------|--------|
| writer_b5 | teamwork_preview_worker | DONE (13 mandatory sections) | report.md |
| reviewer_b5 | teamwork_preview_reviewer | APPROVE (Tier 4 verified) | tests/test_benchmark_b4_b5.py |
| auditor_b5 | teamwork_preview_auditor | CLEAN (10/10 rules verified) | report.md |

Gate Result: **PASS**
All acceptance criteria for Milestone B5 (Requirement R7 part 2) have been verified:
1. `report.md`: Completely rewritten into 13 mandatory numbered sections with strict separation of Axis A (Biophysics) and Axis B (Selectivity).
2. Explicit catalog of retracted, corrected, and de-hyped claims (Section 13).
3. 100% automated test pass rate across unit, integration, adversarial, and benchmark suites.
4. Zero fabrications, zero unvalidated drug claims, and 100% concordance with established primary literature.
